載入...
Principles for designing future regimens for multidrug-resistant tuberculosis
Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes. One of the biggest barriers to scale-up is the treatment regimen, which is lengthy, complex, ineffective, poorly tolerated and expensive. For t...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
World Health Organization
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3865549/ https://ncbi.nlm.nih.gov/pubmed/24391302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.13.122028 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|